Leveraging the potential of mobile phone text messaging, the Be He@lthy, Be Mobile initiative started in 2012 as a joint initiative between the World Health Organization (WHO) and the International Telecommunication Union (ITU) . It was established in direct response to the United Nations General Assembly’s call for concerted action on noncommunicable diseases (NCDs) in 2011, and supports the 2030 Sustainable Development Goals (SDGs). Using innovative multisectworal partnership models, Be He@lthy, Be Mobile works to design, deploy and scale-up national NCD
prevention and management services which can be run using mobile phones. It is currently working with governments in 10 countries across a range of income groups and disease areas.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents research-based biopharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health (www.ifpma.org). Research-based pharmaceutical companies have a unique role as innovators of life-saving and life-changing medicines and vaccines, which improved millions of lives around the world. Both IFPMA and its companies are involved in hundreds of partnerships, including the new Access Accelerated (www.accessaccelerated.org) initiative, a partnership of over 20 biopharmaceutical companies developing innovative and sustainable solutions to improve access to non-communicable disease (NCDs) treatment and care in low- and middle income countries. Recognizing the huge potential mobile technology has to leap-frog and overcome barriers, IFPMA joined forces with Be He@lthy, Be Mobile, sharing with national governments best practices for mobile health strategies and providing important information on disease prevention and management direct to mobile phone users